Tyra Biosciences, Inc. (TYRA)
28.65
+3.79
(+15.25%)
USD |
NASDAQ |
Sep 04, 16:00
28.70
+0.05
(+0.17%)
After-Hours: 20:00
Tyra Biosciences Market Cap : 1.709B for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 1.709B |
| September 03, 2026 | 1.483B |
| September 02, 2026 | 1.499B |
| September 01, 2026 | 1.509B |
| August 31, 2026 | 1.493B |
| August 28, 2026 | 1.488B |
| August 27, 2026 | 1.559B |
| August 26, 2026 | 1.564B |
| August 25, 2026 | 1.592B |
| August 24, 2026 | 1.557B |
| August 21, 2026 | 1.554B |
| August 20, 2026 | 1.533B |
| August 19, 2026 | 1.600B |
| August 18, 2026 | 1.554B |
| August 17, 2026 | 1.564B |
| August 14, 2026 | 1.509B |
| August 13, 2026 | 1.493B |
| August 12, 2026 | 1.509B |
| August 11, 2026 | 1.502B |
| August 10, 2026 | 1.566B |
| August 07, 2026 | 1.582B |
| August 06, 2026 | 1.609B |
| August 05, 2026 | 1.534B |
| August 04, 2026 | 1.941B |
| August 03, 2026 | 1.912B |
| Date | Value |
|---|---|
| July 31, 2026 | 1.896B |
| July 30, 2026 | 1.966B |
| July 29, 2026 | 1.850B |
| July 28, 2026 | 1.836B |
| July 27, 2026 | 1.847B |
| July 24, 2026 | 1.822B |
| July 23, 2026 | 1.832B |
| July 22, 2026 | 1.819B |
| July 21, 2026 | 1.894B |
| July 20, 2026 | 1.847B |
| July 17, 2026 | 1.911B |
| July 16, 2026 | 1.880B |
| July 15, 2026 | 1.926B |
| July 14, 2026 | 1.955B |
| July 13, 2026 | 1.943B |
| July 10, 2026 | 1.948B |
| July 09, 2026 | 1.963B |
| July 08, 2026 | 1.937B |
| July 07, 2026 | 1.899B |
| July 06, 2026 | 1.835B |
| July 02, 2026 | 1.821B |
| July 01, 2026 | 1.749B |
| June 30, 2026 | 1.899B |
| June 29, 2026 | 1.910B |
| June 26, 2026 | 1.896B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CG Oncology, Inc. | 6.594B |
| Arrowhead Pharmaceuticals, Inc. | 12.19B |
| Oncolytics Biotech, Inc. | 105.09M |
| Sangamo Therapeutics, Inc. | 66.70M |
| Sarepta Therapeutics, Inc. | 2.377B |
Market Cap Related Metrics
| PEG Ratio | -0.3531 |
| Price to Book Value | 4.833 |
| Price | 28.65 |
| Earnings Yield | -8.35% |
| PEGY Ratio | -0.3531 |